In this Review:
Infliximab for immunotherapy associated colitis
Screening investigations for Wilson’s disease and α1-antitrypsin deficiency
The duodenal microbiota in chronic liver disease
Elevated ALT: prevalence & relationship to metabolic cofactors
Survival benefits for MDT care in hepatocellular carcinoma
Sofosbuvir + daclatasvir for decompensated HCV cirrhosis
Response predictors in nucleotide analogue/immunomodulator HBV therapy
The natural history of immune escape HBV infection
Thyroid dysfunction & SVR rates in triple therapy for HCV
MicroRNAs as serum biomarkers in chronic hepatitis C
Please login below to download this issue (PDF)